LabConnect Appoints Mitch Blumenfeld as New Chief Financial Officer

LabConnect Welcomes Mitch Blumenfeld as CFO

LabConnect, a prominent player in the central laboratory services sector, is thrilled to announce the appointment of Mitch Blumenfeld as its new Chief Financial Officer (CFO), effective August 4, 2025. This strategic addition to the leadership team underscores LabConnect's commitment to fostering growth and operational excellence, which are paramount to the company's ongoing success.

A Wealth of Experience

Mitch Blumenfeld joins LabConnect with a rich background, having amassed over 30 years of experience in financial leadership roles across a range of sectors. His extensive career includes serving as CFO in high-growth companies within the pharmaceutical services, pharmaceutical wholesale distribution, diversified manufacturing, and consumer products industries. His diverse experience is expected to be instrumental in guiding LabConnect through its next chapter.

Prior to his role at LabConnect, Blumenfeld was the CFO for Network Partners Group, a global consulting firm specializing in life sciences and medical devices. There, he managed financial strategies and operations, ensuring that the company maintained its competitive edge in delivering essential regulatory and quality services. Moreover, he has held significant positions at Signant Health, recognized for its market-leading clinical research software and services, and at PCI Pharma Services, a contract development and manufacturing organization. His previous executive roles at AmerisourceBergen Corporation and various business units within General Electric add further depth to his qualifications.

Leadership Remarks

Wes Wheeler, CEO of LabConnect, expressed enthusiasm about Blumenfeld's appointment, stating, "We are delighted to welcome Mitch to LabConnect and our executive team. His leadership qualities and expertise in finance will be crucial in driving LabConnect’s profitable growth, achieving operational excellence, and advancing our capital allocation priorities." This sentiment reflects a broad confidence in Blumenfeld’s ability to lead the financial organization of LabConnect effectively.

As COO, Blumenfeld will steer the organization’s global finance team, overseeing critical functions such as corporate finance, accounting, treasury, financial planning and analysis, taxation, and investor relations. His role is essential in positioning LabConnect for future success.

Mitch Blumenfeld's Vision

Upon his appointment, Blumenfeld shared his excitement: "I am thrilled to join LabConnect at such a pivotal time. The company is redefining central laboratory services globally, and I look forward to contributing to this transformation." His forward-thinking approach aligns with the innovative spirit that fosters LabConnect's mission.

About LabConnect

LabConnect is celebrated as a highly agile central laboratory solutions partner. The company specializes in providing customized, orchestrated, scalable, and technology-focused support services for clinical trials of all sizes and complexities. With a remarkable track record that spans over 20 years and more than 2,000 clinical studies conducted in 93 countries, LabConnect has established itself as the trusted partner for biotechnology, pharmaceutical, and clinical research organizations worldwide.

Leveraging modern operations and strategic alliances with globally recognized laboratories, LabConnect is well-positioned to access the latest innovations and automation technologies. The company excels by delivering exceptional service through a comprehensive suite of central laboratory solutions, including customized laboratory kits, advanced sample tracking, integrated logistics, standardized sample processing on a global scale, and an extensive testing menu that offers over 20,000 validated assays. Their offerings also include global support for radiopharmaceutical products and next-generation biobanking solutions.

LabConnect’s scientific experts support preclinical and clinical studies with project management, biological and bioanalytical sample management, biomarker strategies, and logistical solutions. Furthermore, LabConnect stands out in data management, effectively integrating complex data sets from various sources into a coherent dataset ready for submission.

To discover more about LabConnect and its innovative solutions, visit LabConnect's website and follow them on LinkedIn for the latest updates.